Medication Adjustments for Low Carb Diets
Short term studies in people with type 1 diabetes have shown that low carbohydrate diets lead to improvements in A1C levels, reduced insulin requirements, less glucose variability, and weight loss. People with type 2 diabetes have shown similar improvements when compared to higher carbohydrate diets or low fat diets. Some also show higher rates of diabetes remission, improved triglyceride levels and a reduced need for medication in the short term.
It is unknown if the improvements seen will be maintained long-term or will result in lower rates of cardiovascular disease or other diabetes complications or mortality. Many studies are limited by poor research quality, so we aren’t able to provide general recommendations for everyone living with diabetes.
Many people have difficulty following low carbohydrate diets for the long term. Even so, given the popularity of low carbohydrate diets amongst the public, it’s common for people to at least profess the desire to start one.
Definitions
Moderate Carbohydrate: >130 g carb/d, 26 – 45% of total energy from carb (Mean ~200 g/d)
Low Carbohydrate: <130 g carb/d, <26% of total energy from carb
Ketogenic: 20 – 50 g carb/d, <10% of total energy from carb
Nutritional Considerations
Note that patients should be strongly encouraged to have a review with a dietitian to ensure that they are getting adequate nutrition, if following a low carbohydrate or ketogenic diet.
Ketones
In research trials including people with type 2 diabetes, mean blood ketone levels have ranged between 0.3 to 0.5 mmol/L, and urine ketones usually don’t go above trace. If you’re concerned that your patient on a ketogenic diet has excessive ketone levels, ask them to check and ensure that blood ketones are no great than 0.8 mmol/L (ideally < 0.6 mmol/L).
Hypoglycemia
People who are following a ketogenic diet and taking insulin or an insulin secretagogue, are strongly encouraged to treat hypoglycemia with fast acting carbohydrate, even if that means their ketone levels will drop over the short term.
Medication Changes and Precautions
Changes to medications might be required for patients who start following a low carbohydrate or ketogenic diet. Consideration should be given to their current carbohydrate intake, how much reduction in carb intake is anticipated and the current glycemic control. The following medication adjustments should be considered, as appropriate:
Medication | Concern | Adjustment to consider |
Insulin |
Risk of hypoglycemia |
Reduce or stop depending on glycemic control and type of diabetes. Insulin should not be stopped completely in insulin deficient diabetes (Type 1, LADA, longstanding Type 2 diabetes). Consider weaning by 30 - 50%: |
Sulfonylurea or Megitinide |
Risk of hypoglycemia |
Reduce or stop depending on glycemic control. Consider successive halving of dose |
SGLT2 inhibitor |
Increased glucosuria, risk of euglycemic ketoacidosis |
No routine medication adjustment, but ensure that the patient knows how to adjust for sick days, and knows the signs and symptoms of DKA. |
Glucagon |
May not be as effective to treat hypoglycemia |
If following a ketogenic diet, people taking insulin should monitor glucose more frequently in situations when there's increased risk of hypoglycemia |
Metformin |
Safe, and may provide clinical benefits |
Optional. Consider clinical pros and cons. |
GLP1 receptor agonist |
Safe, and may provide clinical benefits (satiety and cardiovascular) |
Optional. Consider clinical pros and cons. |
Thiazolidenedione |
Safe on a low carb diet. Consider known possible side effects. |
Optional. Consider clinical pros and cons. |
DPP4 inhibitor |
Safe, but likely little glycemic benefit |
Optional. Consider clinical pros and cons. |
Alpha glucosidase inhibitor |
Safe, but likely little glycemic benefit |
Usually stop because there's no benefit, as few disaccharides with low carb diet. |